Article information
Resumo
As pneumonias intersticiais idiopáticas (PII) são um grupo de doenças de difícil estudo e abordagem clínica, devido a vários factores, dos quais se destacam a sua raridade e a enorme discrepância nas descrições dos achados clínicos, imagiológicos e histológicos pelos vários autores. Um dos espelhos desta discrepância é o problema da classificação das várias entidades que constituem este grupo e que apenas em 2002 começou a esboçar algum consenso entre as autoridades na matéria.
O objectivo desta revisão é compilar a literatura mais relevante, de modo a facilitar a compreensão de um tema tão complexo.
Palavras-chave:
Pneumonias intersticiais idiopáticas
fibrose pulmonar idiopática
Abstract
Interstitial idiopathic pneumonias are a group of diseases whose rarity and variety of clinical, radiological and pathological descriptions creates difficulties in study and management. An example of this is the classification method for this group, with only 2002 seeing some consensus.
The aim of this article is to review the main literature to contribute to an understanding of this subject.
Key-words:
Interstitial idiopathic pneumonias
idiopathic pulmonary fibrosis
Full text is only aviable in PDF
Bibliografia
[1.]
M.J. Thomeer, et al.
Comparison of registries of interstitial lung diseases in three European countries.
Eur Respir J, 18 (2001), pp. 114s-118s
[2.]
J.H. Ryu, et al.
Idiopathic Pulmonary Fibrosis: Current Concepts.
Mayo Clin Proc, 73 (1998), pp. 1085-1091
[3.]
T.J. Gross, G.W. Hunninghake.
Idiopathic Pulmonary Fibrosis.
N Engl J Med, 345 (2001), pp. 517-525
[4.]
American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias.
Am J Respir Crit Care Med, 165 (2002), pp. 277-304
[5.]
M. Harasawa, Y. Fukuchi, H. Morinari.
Interstitial pneumonia of unknown etiology.
University of Tokyo Press, (1989),
[6.]
R.G. Crystal, J. Gadek, V. Ferrans.
Interstitial lung diseases: current concept of pathogenesis, staging and therapy.
Am J Med, 70 (1981), pp. 542-568
[7.]
L. Hamman, A.R. Rich.
Acute diffuse interstitial fibrosis of the lungs.
Bull Johns Hopkins Hosp, 74 (1944), pp. 177-212
[8.]
J. Olson, T.V. Colby, C.G. Elliott.
Hamman-Rich syndrome revisited.
Mayo Clin Proc, 65 (1990), pp. 1538-1548
[9.]
J.G. Scadding, K.F. Hinson.
Diffuse fibrosing alveolitis (diffuse interstitial fibrosis of the lungs): correlation of histology at biopsy with prognosis.
Thorax, 22 (1967), pp. 291-304
[10.]
A.A. Katzenstein, R.F. Fiorelli.
Nonspecific Interstitial Pneumonia/Fibrosis – Histologic Features and Clinical Significance.
Am J Surg Pathol, 18 (1994), pp. 136-147
[11.]
R.M. Du Bois, A.U. Wells.
Cryptogenic fibrosing alveolitis/idiopathic pulmonary fibrosis.
Eur Respir J, 18 (2001), pp. 43s-55s
[12.]
C.B. Carrington, et al.
Natural history and treated course of usual and desquamative interstitial pneumonia.
N Engl J Med, 298 (1978), pp. 801-809
[13.]
A.G. Davison, et al.
Cryptogenic organizing pneumonitis.
Q J Med, 207 (1983), pp. 382-394
[14.]
J.L. Myers, et al.
Respiratory bronchiolitis causing interstitial lung disease. A clinicopathologic study of six cases.
Am Rev Respir Dis, 135 (1987), pp. 880-884
[15.]
A.L. Katzenstein, J.L. Myers.
Idiopathic Pulmonary Fibrosis, clinical relevance of pathological classification.
Am J Respir Crit Care Med, 157 (1998), pp. 1301-1315
[16.]
G.R. Epler, et al.
Bronchiolitis obliterans organizing pneumonia.
N Engl J Med, 312 (1985), pp. 152-158
[18.]
Idiopathic Pulmonary Fibrosis: Diagnosis and Treatment – International Consensus Statement.
Am J Respir Crit Care Med, 161 (2000), pp. 646-664
[19.]
G.M. Verleden, et al.
Genetic predisposition and pathogenetic mechanisms of interstitial lung diseases of unknown origin.
Eur Respir J, 18 (2001), pp. 17S-29S
[20.]
M. Demedts, et al.
Interstitial lung diseases: an epidemiological overview.
Eur Respir J, 18 (2001), pp. 2S-16S
[21.]
T.E. King, et al.
Idiopathic pulmonary fibrosis: diagnosis and treatment.
Am J Respir Crit Care Med, 161 (2000), pp. 646-664
[22.]
Z.D. Daniil, et al.
A histologic pattern of nonspecific interstitial pneumonia is associated with a better prognosis than usual interstitial pneumonia with cryptogenic fibrosing alveolitis.
Am J Respir Crit Care Med, 160 (1999), pp. 899-905
[23.]
T.E. King, R.L. Mortenson.
Cryptogenic organizing pneumonitis. The North American experience.
Chest, 102 (1992), pp. 8S-13S
[24.]
D. Moniz.
Pneumonias intersticiais idiopáticas – abordagem diagnóstica.
Rev Port Pneumol, VII (2001), pp. 386-392
[25.]
R. Ziesche, et al.
A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis.
N Engl J Med, 341 (1999), pp. 1262-1269
[26.]
G. Raghu, et al.
A Placebo-Controlled Trial of Interferon Gamma-1b in Patients with Idiopathic Pulmonary Fibrosis.
N Engl J Med, 350 (2004), pp. 125-133
[27.]
T.E. King, et al.
Analyses of Efficacy End Points in a Controlled Trial of Interferon-γ 1b for Idiopathic Pulmonary Fibrosis.
Chest, 127 (2005), pp. 171-177
[28.]
International guidelines for the selection of lung transplant candidates.
Am J Respir Crit Care Med, 158 (1998), pp. 335-339
[29.]
J.A. Bjoraker, et al.
Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis.
Am J Respir Crit Care Med, 157 (1998), pp. 199-203
[30.]
C.B. Carrington, et al.
Natural history and treated course of usual and desquamative interstitial pneumonia.
N Engl J Med, 298 (1978), pp. 801-809
Copyright © 2006. Sociedade Portuguesa de Pneumologia
